Article Text

Download PDFPDF

Glucagon-like peptide-1: a potent regulator of food intake in humans

Abstract

Background/Aims Studies in animals suggest a physiological role for glucagon-like peptide-1-(7–36)-amide (GLP-1) in regulating satiety. The role of GLP-1 in regulating food intake in man has, however, not been investigated.

Subjects—Sixteen healthy male subjects were examined in a double blind placebo controlled fashion.

Methods The effect of graded intravenous doses (0, 0.375, 0.75, and 1.5 pmol/kg/min) of synthetic human GLP-1 on food intake and feelings of hunger and satiety was tested in healthy volunteers.

Results Graded GLP-1 infusions resulted in a dose dependent reduction in food intake (maximal inhibition 35%, p<0.001 vcontrol) and a similar reduction in calorie intake (32%; p<0.001). Fluid ingestion was also reduced by GLP-1 (18% reduction, p<0.01). No overt side effects were produced by GLP-1, but subjects experienced less hunger and early fullness in the period before a meal during GLP-1 infusion at the highest dose (p<0.05).

Conclusions Intravenous infusions of GLP-1 decrease spontaneous food intake even at physiological plasma concentrations, implying an important role for GLP-1 in the regulation of the early satiety response in humans.

  • glucagon-like peptide-1
  • satiety
  • food intake
  • hunger and fullness score
  • Abbreviations

    GLP-1
    glucagon-like peptide-1
    CCK
    cholecystokinin
  • View Full Text

    Statistics from Altmetric.com

  • Abbreviations

    GLP-1
    glucagon-like peptide-1
    CCK
    cholecystokinin
  • View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.